Published online before print July 8, 2004, doi: 10.1161/01.RES.0000138018.61065.d1
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 1, 2003
Revised on June 21, 2004
Accepted on June 24, 2004
Angiogenic Effects of Adrenomedullin in Ischemia and Tumor Growth
Satoshi Iimuro ;
From the From the Department of Cardiovascular Medicine (S.I., T.S., T.A., P.N., N.T., H.I., Y.Z., A.E., R.N.), Graduate School of Medicine, University of Tokyo; and Department of Experimental Nursing (N.M.), Faculty of Nursing, Fukuoka Prefectural University, Japan.
* To whom correspondence should be addressed. E-mail: shindo-tky{at}umin.ac.jp.
Adrenomedullin (AM) is a novel vasodilating peptide involved in the regulation of circulatory homeostasis and implicated in the pathophysiology of cardiovascular disease. We tested the hypothesis that AM also possesses angiogenic properties. Using laser Doppler perfusion imaging, we found that AM stimulated recovery of blood flow to the affected limb in the mouse hind-limb ischemia model. AM exerted this effect in part by promoting expression of vascular endothelial growth factor (VEGF) in the ischemic limb, and immunostaining for CD31 showed the enhanced flow to reflect increased collateral capillary density. By enhancing tumor angiogenesis, AM also promoted the growth of subcutaneously transplanted sarcoma 180 tumor cells. However, heterozygotic AM knockout mice (AM+/-) showed significantly less blood flow recovery with less collateral capillary development and VEGF expression than their wild-type littermates. Similarly, mice treated with AM22-52, a competitive inhibitor of AM, showed reduced capillary development, and growth of sarcoma 180 tumors was inhibited in AM+/- and AM22-52-treated mice. Notably, administration of VEGF or AM rescued blood flow recovery and capillary formation in AM+/- and AM22-52-treated mice. In cocultures of endothelial cells and fibroblasts, AM enhanced VEGF-induced capillary formation, whereas in cultures of endothelial cells AM enhanced VEGF-induced Akt activation. These results show that AM possesses novel angiogenic properties mediated by its ability to enhance VEGF expression and Akt activity. This may make AM a useful therapeutic tool for relieving ischemia; conversely, inhibitors of AM could be useful for clinical management of tumor growth.
Key words: angiogenesis • ischemia • vascular biology • vascular endothelial growth factor
This article has been cited by other articles:
 |
|
 |
|
  W. Schgoer, M. Theurl, J. Jeschke, A. G.E. Beer, K. Albrecht, R. Gander, S. Rong, D. Vasiljevic, M. Egger, A. M. Wolf, et al. Gene Therapy With the Angiogenic Cytokine Secretoneurin Induces Therapeutic Angiogenesis by a Nitric Oxide-Dependent Mechanism Circ. Res., November 6, 2009; 105(10): 994 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Damianovich, M. Blank, A. Raiter, B. Hardy, and Y. Shoenfeld Anti-vascular endothelial growth factor (VEGF) specific activity of intravenous immunoglobulin (IVIg) Int. Immunol., September 1, 2009; 21(9): 1057 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Jin, K. Harada, S. Ohnishi, K. Yamahara, K. Kangawa, and N. Nagaya Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema Cardiovasc Res, December 1, 2008; 80(3): 339 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nicoli, C. Tobia, L. Gualandi, G. De Sena, and M. Presta Calcitonin receptor-like receptor guides arterial differentiation in zebrafish Blood, May 15, 2008; 111(10): 4965 - 4972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Egger, W. Schgoer, A. G. E. Beer, J. Jeschke, J. Leierer, M. Theurl, S. Frauscher, O. M. Tepper, A. Niederwanger, A. Ritsch, et al. Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1{alpha}- and basic FGF-dependent pathway in muscle cells FASEB J, September 1, 2007; 21(11): 2906 - 2917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ribatti, M. T. Conconi, and G. G. Nussdorfer Nonclassic Endogenous Novel Regulators of Angiogenesis Pharmacol. Rev., June 1, 2007; 59(2): 185 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Schwarz, D. Renshaw, S. Kapas, and J. P Hinson Adrenomedullin increases the expression of calcitonin-like receptor and receptor activity modifying protein 2 mRNA in human microvascular endothelial cells. J. Endocrinol., August 1, 2006; 190(2): 505 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Miyashita, H. Itoh, H. Arai, T. Suganami, N. Sawada, Y. Fukunaga, M. Sone, K. Yamahara, T. Yurugi-Kobayashi, K. Park, et al. The Neuroprotective and Vasculo-Neuro-Regenerative Roles of Adrenomedullin in Ischemic Brain and Its Therapeutic Potential Endocrinology, April 1, 2006; 147(4): 1642 - 1653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nag, A. Kato, T. Nakada, K. Hoshijima, A. C. Mistry, Y. Takei, and S. Hirose Molecular and functional characterization of adrenomedullin receptors in pufferfish Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R467 - R478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kato, T. Tsuruda, T. Kita, K. Kitamura, and T. Eto Adrenomedullin: A Protective Factor for Blood Vessels Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2480 - 2487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, K. E. Green, C. Yallampalli, and Y. L. Dong Adrenomedullin Enhances Invasion by Trophoblast Cell Lines Biol Reprod, October 1, 2005; 73(4): 619 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagaya, H. Mori, S. Murakami, K. Kangawa, and S. Kitamura Adrenomedullin: angiogenesis and gene therapy Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1432 - R1437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kaur, F. W. Khwaja, E. A. Severson, S. L. Matheny, D. J. Brat, and E. G. Van Meir Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis Neuro-oncol, April 1, 2005; 7(2): 134 - 153. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Iwase, N. Nagaya, T. Fujii, T. Itoh, H. Ishibashi-Ueda, M. Yamagishi, K. Miyatake, T. Matsumoto, S. Kitamura, and K. Kangawa Adrenomedullin Enhances Angiogenic Potency of Bone Marrow Transplantation in a Rat Model of Hindlimb Ischemia Circulation, January 25, 2005; 111(3): 356 - 362. [Abstract] [Full Text] [PDF]
|
|